Live Plague Vaccine Development: Past, Present, and Future

Live Plague Vaccine Development: Past, Present, and Future

During the last 100 years, vaccine development has evolved from an empirical approach to one of the more rational vaccine designs where the careful selection of antigens and adjuvants is key to the desired efficacy for challenging pathogens and/or challenging populations. To improve immunogenicity w...

Full description

Saved in:

Bibliographic Details
Main Authors:	Andrey P. Anisimov, Anastasia S. Vagaiskaya, Alexandra S. Trunyakova, Svetlana V. Dentovskaya
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Vaccines
Subjects:	<i>Yersinia pestis</i> plague vaccine live vaccine
Online Access:	https://www.mdpi.com/2076-393X/13/1/66
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anthropological view of plague epidemics in the historical past
by: T.F. Khaydarov, et al.
Published: (2021-12-01)

Putting Africa on the Black Death map: Narratives from genetics and history
by: Monica H. Green
Published: (2018-12-01)

Genetically Engineered Bacterial Ghosts as Vaccine Candidates Against <i>Klebsiella pneumoniae</i> Infection
by: Svetlana V. Dentovskaya, et al.
Published: (2025-01-01)

Elucidation of peptide screen for targeted identification of Yersinia pestis by nano-liquid chromatography tandem mass spectrometry
by: Priya Rani, et al.
Published: (2025-01-01)

Viral Live‐Attenuated Vaccines (LAVs): Past and Future Directions
by: Yan‐Dong Tang, et al.
Published: (2025-01-01)

Recognizing plague epidemics in the archaeological record of West Africa
by: Daphne E. Gallagher, et al.
Published: (2018-12-01)

Evaluation of 16S rRNA genes sequences and genome-based analysis for identification of non-pathogenic Yersinia
by: Angelina A. Kislichkina, et al.
Published: (2025-01-01)

Stability and Efficacy of Live-Attenuated Vibrio harveyi Vaccines Under Different Storage Conditions in Zebrafish (Danio rerio) Models
by: Mohd Hafiz Ngoo Muhamad-Sofie, et al.
Published: (2024-09-01)

Chitosan Nanoparticles for Enhanced Immune Response and Delivery of Multi-Epitope <i>Helicobacter pylori</i> Vaccines in a BALB/c Mouse Model
by: Rita Amaral, et al.
Published: (2025-01-01)

Development of nucleic acid-based vaccines against dengue and other mosquito-borne flaviviruses: the past, present, and future
by: Muhammad Bashir Bello, et al.
Published: (2025-01-01)

Pertussis Vaccination for Adults: An Updated Guide for Clinicians
by: Kay Choong See
Published: (2025-01-01)

A new vaccination approach for Salmonellosis employing a multi-epitope vaccine based on live microbial cell factory from Lactococcus lactis
by: Reyhaneh Sadat Moosavi-Kohnehsari, et al.
Published: (2025-02-01)

Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms
by: Mie Suzuki Okutani, et al.
Published: (2025-02-01)

Reflections on plague in African history (14th–19th c.)
by: Gérard Chouin
Published: (2018-12-01)

Elegant and Innovative Recoding Strategies for Advancing Vaccine Development
by: François Meurens, et al.
Published: (2025-01-01)

Expert consensus and recommendations on the live attenuated hepatitis A vaccine and immunization practices in India
by: Nitin Shah, et al.
Published: (2025-12-01)

An epidemiological modeling investigation of the long-term changing dynamics of the plague epidemics in Hong Kong
by: Salihu S. Musa, et al.
Published: (2024-10-01)

Cases of detection of serotype 14 bluetongue vaccine-like virus in the RF and European countries in 2011-2012
by: V. M. Zakharov, et al.
Published: (2018-04-01)

The impact of vaccines and vaccinations: Challenges and opportunities for modelers
by: Roy Curtiss III
Published: (2010-12-01)

Modelled Public Health Impact of Introducing Adjuvanted Recombinant Zoster Vaccine into the UK National Immunisation Programme
by: Manjit Hunjan, et al.
Published: (2024-11-01)

Cell Wall Protein 2 as a Vaccine Candidate Protects Mice Against <i>Clostridioides difficile</i> Infection
by: Shaohui Wang, et al.
Published: (2024-12-01)

Comparison of Long-Term Antibody Titers in Calves Treated with Different Conjunctival and Subcutaneous <i>Brucella abortus</i> S19 Vaccines
by: Ali Uslu, et al.
Published: (2025-01-01)

Effectiveness of iNTS vaccination in sub-Saharan Africa
by: Daniele Cassese, et al.
Published: (2025-01-01)

Study of the vaccination effects against <i>Staphylococcus aureus</i>, causing mastitis and endometritis in cows
by: E. V. Ivanov, et al.
Published: (2024-12-01)

Safety, Tolerability, and Immunogenicity of the Invaplex<sub>AR-Detox</sub> <i>Shigella</i> Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial
by: Geert V. T. Roozen, et al.
Published: (2025-01-01)

Protective Efficacy of Decreasing Antigen Doses of a <i>Chlamydia abortus</i> Subcellular Vaccine Against Ovine Enzootic Abortion in a Pregnant Sheep Challenge Model
by: Morag Livingstone, et al.
Published: (2025-01-01)

Yaws in Africa: Past, Present and Future
by: Ezekiel K. Vicar, et al.
Published: (2025-01-01)

DDO-adjuvanted influenza A virus nucleoprotein mRNA vaccine induces robust humoral and cellular type 1 immune responses and protects mice from challenge
by: Victoria Gnazzo, et al.
Published: (2025-02-01)

Development of a Recombinant Fusion Vaccine Candidate Against Lethal <i>Clostridium botulinum</i> Neurotoxin Types A and B
by: Eun-Sun Choi, et al.
Published: (2025-01-01)

Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children
by: Stephanie A. Davey, et al.
Published: (2025-12-01)

The Expressions of the Immunity- and Muscle Development-Related Genes of 40-Day-Old Broilers Are Promoted in Response to the <i>In Ovo</i> and Dietary Supplemental Administration of Calcidiol in Conjunction with the <i>In Ovo</i> Administration of Marek’s Disease Vaccine
by: Seyed Abolghasem Fatemi, et al.
Published: (2024-12-01)

Preferences for and drivers of adult vaccination clinic site selection: A cross-sectional study in 30 provinces in China
by: Yuxi Liu, et al.
Published: (2025-12-01)

Maternal F1 antibodies and cytokines in mother-neonate dog pairs in the Marmota himalayana plague focus
by: Deming Tang, et al.
Published: (2025-02-01)

Parental Attitudes, Motivators and Barriers Toward Children’s Vaccination in Poland: A Scoping Review
by: Krystyna Szalast, et al.
Published: (2025-01-01)

What is a vaccine?
by: Melissa K. Jones, et al.
Published: (2022-06-01)

Influencing factors for influenza vaccination among the elderly
by: LI Yiyao, LI Xiaoju, SHEN Xiaoying, ZHANG Xianqi, ZHAO Li, ZHANG Yuhan, WANG Xinmeng
Published: (2025-01-01)

Advances in nucleic acid-based cancer vaccines
by: Hung-Chun Liao, et al.
Published: (2025-01-01)

A Nanoparticle Comprising the Receptor-Binding Domains of Norovirus and <i>Plasmodium</i> as a Combination Vaccine Candidate
by: Ming Xia, et al.
Published: (2025-01-01)

The Evaluation of the Efficacy of a Novel Subunit Vaccine in the Prevention of <i>Cryptosporidium parvum</i>-Caused Diarrhoea in Neonatal Calves
by: Martine Reijnders, et al.
Published: (2025-01-01)

Editorial: Building public confidence in innovative mRNA vaccines
by: Jia Hu, et al.
Published: (2025-01-01)